Superstar Shah Rukh Khan’s ‘Jawan’ has found its way into the top five movies at the US Box Office for releases in September 2023. The film, distributed by Yash Raj Films USA Inc, was released on September 7 and amassed a total gross of $12,108,639 ( ₹100 crore) in the US. Notably, this feat was achieved in just 826 theatres, far fewer than its Hollywood counterparts, as per Box Office Mojo.
September 2023 was a competitive month at the US Box Office, with ‘The Equalizer 3’ leading the pack, earning $73,673,848 ( ₹613 crore). It was followed by ‘The Nun II’, which garnered $56,327,738 ( ₹469 crore). Also featured in the list is ‘My Big Fat Greek Wedding 3’ at the fourth spot with $18,632,245 ( ₹155 crore). ‘Barbie and Oppenheimer’, released on July 21, are still among the top 10 movies in September.
Breaking into this Hollywood-heavy list, ‘Jawan’ has claimed the fifth position among September releases. Considering the limited number of theatres in which it was shown, the film’s per-theatre earnings are quite impressive. This stands as a strong testament to the film’s appeal and the growing influence of Indian movies on international audiences.
As per Sacnilk’s early estimates, ‘Jawan’ earned ₹16 crore on Day 12, taking the domestic Box Office collection to ₹493.63 crore. The movie has sold 1.15 lakh tickets for Day 13 and is likely to mint ₹2.22 crore in India soon.
Shah Rukh Khan’s latest offering, directed by Atlee, looks likely to get past Sunny Deol’s August release, ‘Gadar 2’. The sequel has earned ₹520.60 crore in 39 days, as per Sacnilk.
Trade analyst Ramesh Bala said that if ‘Jawan’, like ‘Pathaan’, makes it to the Rs 1,000 crore club, which is highly likely, it will definitely be a “rare occurrence” for Hindi cinema.
In India, Karan Taurani of Elara Capital points out, ‘Jawan’ has no real competition in the near future, for the next Hindi releases (scheduled for September 28) are ‘Fukrey 3’, which has a niche audience, and Vivek Ranjan Agnihotri’s ‘The Vaccine War’.
